Company / Accounts Receivable
Avantor Accounts Receivable History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.1B
FY2025
5-year range
$1.0B / $1.2B
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#23 of 138
Health Care
What the data says
Avantor's accounts receivable of $1.1B is higher than 83% of companies in the Health Care sector (FY2025). Accounts Receivable returned to growth in FY2025 after 3 years of decline, reaching $1.1B.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of -0.7%. Top quartile in the Health Care sector.
Declined from $1.2B to $1.1B over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -4.1%
- 5-Year CAGR
- -0.7%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 138This company $1.1B Sector average $1.3B
▼
-18.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.7%, indicating a declining trend.
- In FY2025, accounts receivable increased 3.9% year-over-year.
- Ranks #23 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +3.9% |
| FY2024 | $1.0B | -10.1% |
| FY2023 | $1.2B | -5.6% |
| FY2022 | $1.2B | -0.3% |
| FY2021 | $1.2B | +9.8% |
| FY2020 | $1.1B | +12.6% |
| FY2019 | $988.8M | +6.2% |
| FY2018 | $931.2M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026